Using augmented reality technology, Endosight is a high-end guidance system for interventional procedures.
Source: R.A.W. S.r.l.

Augmented reality

Bracco Imaging reinforces its portfolio in Interventional Oncology

Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced a strategic partnership with R.A.W. S.r.l. - an Italian company focused on Augmented Reality Guidance technology in Interventional Oncology procedures - to expand its portfolio of solutions for Interventional Oncology.

One of the key challenges clinicians have to face during interventional procedures is the precise introduction of a probe into a deep target within the body that is not visible. Clinical efforts in this field have been concentrated toward developing higher resolution images, better navigation and image fusion tools. To address these clinical needs, R.A.W. developed Endosight a high-end guidance system based on augmented reality and a sophisticated imaging software (Ablation-fit) for 3D reconstruction, planning and diagnosis to be used in surgery during mini-invasive Percutaneous Tumor Ablation procedures in Computed Tomography-based Interventional Oncology. The solution has been developed to provide intuitive visualization with no need for manipulation or further interaction to ensure accurate targeting, without compromising workflow, procedure duration, or interventional outcomes.

We’re delighted about this partnership as it will unleash new opportunities to address unmet medical needs in the field of Interventional Oncology

Fulvio Renoldi Bracco

“In our clinical studies, Ablation-fit demonstrated a unique ability to predict recurrences beyond the eye perception of radiologist,” said Luigi Solbiati, Professor of Radiology at Humanitas University (Rozzano - Milan, Italy), Consultant of Interventional Radiology at Humanitas Research Hospital and Scientific Director at R.A.W. “In preclinical studies, Endosight demonstrated unparalleled performances that make it possible to “see through” the patient without the need for direct imaging support, thanks to the augmented reality. I have been developing imaging innovations for more than 30 years, and I consider Bracco’s innovative culture the best environment to make new methods grow and spread.”

“We’re delighted about this partnership as it will unleash new opportunities to address unmet medical needs in the field of Interventional Oncology,” said Fulvio Renoldi Bracco, Chief Executive Officer at Bracco Imaging. “Endosight and Ablation-fit will further expand our portfolio of solutions with technologies that, I’m convinced, will significantly impact the clinician effectiveness during the procedure and the patient outcome.”

“We are very excited about the agreement with Bracco Imaging,” said Alessandro Rotilio, Chief Executive Officer at R.A.W. “This partnership is the beginning of an unedited integration of imaging, guidance and treatment. The innovations behind Endosight and Ablation-fit are paradigmatic, and new developments are going to further complete the portfolio. We are first-movers, and we want to keep this advantage with such strategic cooperation. Our vision is to make high-end innovation and to keep the user experience simple.”

“Bracco’s journey focuses on the exploitation of new image-guided solutions for diagnosis and treatment of oncological diseases via internal developments and alliances,” said Micol Fornaroli, Chief Strategy Officer at Bracco Imaging. “Joining forces with R.A.W. is an important step along this pathway as it will give the interventional oncologists top-tier, highly innovative tools to plan, verify and manage patients undergoing interventional oncology procedures,” she concluded.

Ablation-fit will be initially distributed in Europe by Bracco Imaging through its commercial network.

Source: Bracco


Read all latest storys

Related articles


Advancing contrast enhanced ultrasound

The ability to demonstrate blood perfusion as well as organ function using contrast agentenhanced ultrasound is quickly finding innovative uses in clinical practice. Contrast-enhanced ultrasound…

Contrast enhancement

Sonic boom with bubbles

Illuminating blood vessels, opening the blood-brain barrier and delivering drugs. What will be the next big thing that tiny microbubbles can do?

The complex science behind microbubbles

At Bracco Suisse SA in Geneva all efforts are dedicated to contrast media for ultrasound scans. During their visit to the firm’s research centre and manufacturing site, Daniela Zimmermann and Ralf…

Related products


Bracco - CT Exprès

Bracco Imaging SpA


Bracco - EmpowerCTA+

Bracco Imaging SpA


Bracco - EmpowerMR

Bracco Imaging SpA

IT systems - Accessories / Complementary systems

Bracco - NEXO [DOSE]

Bracco Imaging SpA

Mobile RIS/PACS viewer

IMAGE Information Systems - Image iQ-4VIEW

IMAGE Information Systems Europe GmbH

Testing devices

Radcal - ACCU-DOSE+

Radcal Corporation